Byrne Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40
Closed -$2.69K 581
2025
Q3
$2.69K Hold
40
﹤0.01% 507
2025
Q2
$3.49K Hold
40
﹤0.01% 484
2025
Q1
$2.73K Hold
40
﹤0.01% 511
2024
Q4
$3.11K Hold
40
﹤0.01% 493
2024
Q3
$2.68K Hold
40
﹤0.01% 493
2024
Q2
$4.58K Hold
40
﹤0.01% 447
2024
Q1
$5.55K Sell
40
-8
-17% -$1.01K ﹤0.01% 426
2023
Q4
$5.94K Hold
48
﹤0.01% 401
2023
Q3
$4K Hold
48
﹤0.01% 410
2023
Q2
$6K Hold
48
﹤0.01% 447
2023
Q1
$6K Buy
+48
New +$5.37K ﹤0.01% 438

Other funds holding DXCM

Byrne Asset Management's DXCM Position: Q4 2025 in Review

Byrne Asset Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 40 shares — an estimated $2.69K sold.

Byrne Asset Management first reported a position in DXCM in Q1 2023 and held it in 11 quarters. The position peaked at $6K in Q2 2023. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Byrne Asset Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Byrne Asset Management sold 40 DexCom shares in Q4 2025, an estimated $2.69K.
  • Byrne Asset Management first reported a position in DexCom in Q1 2023 and held it in 11 quarters.
  • Byrne Asset Management's DexCom position peaked at $6K in Q2 2023.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Byrne Asset Management's 13F filing for Q4 2025, filed 12 Jan 2026.